ReviewInternational journal of clinical oncology2008

Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?

Barry Iacopetta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.